Fundraising Fox
RxE2
Fargo, US · Founded 2021 · Delaware corporation
Find your way into RxE2
Sign up to see every warm intro you have to RxE2
- Paths you didn't know you had: your email and LinkedIn already hold routes to the RxE2 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
RxE2 runs community-based clinical trials by using community pharmacies as clinical sites, connecting trial sponsors with a network of pharmacies for patient recruitment, direct patient access, and decentralized trial visits. It operates in the clinical research and pharmaceutical trials sector.
Founders & leadership
RxE2 was founded in 2021 by Gerald E. Finken, R.Ph., M.S..
GE
Gerald E. Finken, R.Ph., M.S.Founder · Chief Executive OfficerA pharmacist by training, Finken founded Clinical Supplies Management (CSM) in 1997 and led it as CEO until 2016, later serving as its Chief Scientific Officer. He also founded Center Point Clinical Services, where he served as Chairman of the Board and then Chief Executive Officer before moving into his current role in 2020.
Reported raises · per SEC filings
Form D private placements$5.5M disclosed across 3 of 4 rounds · 2021
▶$1offeredApr 2021 · OtherRule 506(b)
▶$1offeredApr 2021 · Other
Rule 506(b)Officers, directors & promoters on the filing
- Gerald E. FinkenExecutive Officer, Director
- Offering amount
- $1
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$2MraisedApr 2021 · OtherRule 506(b)
▶$2MraisedApr 2021 · Other
Rule 506(b)Officers, directors & promoters on the filing
- Gerald E. FinkenExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$3.5MraisedApr 2021 · 9 investors · OtherRule 506(b)
▶$3.5MraisedApr 2021 · 9 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Gerald FinkenExecutive Officer, Director
- Offering amount
- $3.5M
- Amount sold
- $3.5M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$1raisedApr 2021 · 4 investors · OtherRule 506(b)
▶$1raisedApr 2021 · 4 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Gerald FinkenExecutive Officer, Director
- Offering amount
- $1
- Amount sold
- $1
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Redsail TechnologiesRedSail Technologies provides pharmacy management systems and integrated pharmacy solutions serving health systems and pharmacy operations across the United States. The company delivers software, automation, and clinical programs to optimize medication management and patient care outcomes in healthcare settings.
RxAnteRxAnte provides tech-enabled, value-based pharmacy care management, including analytics and quality-improvement tools plus high-touch pharmacy services, for health plans, providers, and pharmacies. Its programs aim to improve medication use and health outcomes for at-risk members while lowering healthcare costs.
RxVantagePlatform connecting healthcare providers with life science experts to access critical information and insights.
Companies working in the same space as RxE2.
In the news
Frequently asked questions
- What does RxE2 do?
- RxE2 runs community-based clinical trials by using community pharmacies as clinical sites, connecting trial sponsors with a network of pharmacies for patient recruitment, direct patient access, and decentralized trial visits. It operates in the clinical research and pharmaceutical trials sector.
- Who founded RxE2?
- RxE2 was founded by Gerald E. Finken, R.Ph., M.S. in 2021.
- How much funding has RxE2 raised?
- RxE2 has disclosed $5.5M raised across 3 of its 4 known rounds.
- Where is RxE2 headquartered?
- RxE2 is headquartered in Fargo, US.